The NociOcular Assay predicts the eye stinging potential of materials, such as cosmetics, sunscreens, surfactants, and ophthalmic products. The assay relies on the expression of functional Transient Receptor Potential Vanilloid type 1 (TRPV1) channels in a clone of the human SH-SY5Y neuroblastoma cell line. The TRPV1 channel is a well characterized pain receptor that is present in tissues associated with the eye. This channel can be activated by chemical stimuli and is thought to be a general mediator of chemically induced pain on the surface of the eye, which can cause a stinging sensation in a clinical setting.
Although several in vitro eye irritation models exist, no current in vitro assay has demonstrated the ability to predict if products which may come in contact with the eyes will cause a stinging sensation. Data supports that the TRPV1 channel is a principle mediator of eye sting and that the NociOcular assay may serve as a simple bioassay to determine sensory response in the eye. The NociOcular assay has been shown to be capable of detecting eye sting potential in a number of product classes and can be a useful pre-clinical screening tool.
The current prediction model for the assay is based on studies with surfactant ingredients and formulations. Current work is focusing on the expansion of the applicability of the assay through investigation of non-surfactant product types such as creams and lotions (eg. sunscreens). Please view the recording of our webinar on the assay and contact us to discuss how the NociOcular assay for eye sting can be incorporated into your testing strategy.